| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.073 | 0.06 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.067 | 0.06 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.06 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.068 | 0.06 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.069 | 0.06 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | 0.064 | 0.06 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | -0.071 | 0.06 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.06 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.056 | 0.06 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.06 |